Skip to main content
Year archive

Acacia Pharma Group PLC — 2020 filings

All 41 regulatory filings released by Acacia Pharma Group PLC (ACPH) in 2020, sourced directly from the official regulator.

41 Filings
2020 Period
2020 filings (41)
Filing Released Lang
Holding(s) in Company
Major Shareholding Notification
2020-12-18 English
Holding(s) in Company
Major Shareholding Notification
2020-12-18 English
Holding(s) in Company
Major Shareholding Notification
2020-12-18 English
Admission to Trading on Euronext Brussels
Share Issue/Capital Change
2020-12-18 English
Publication of Supplementary Prospectus
Report Publication Announcement
2020-12-17 English
Acacia Pharma Group plc - Supplementary Prospectus
Regulatory Filings
2020-12-15 English
Correction: Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™
Regulatory Filings
2020-12-15 English
Director/PDMR Shareholding
Director's Dealing
2020-10-13 English
Director/PDMR Shareholding
Director's Dealing
2020-10-13 English
Issue of Shares to Employee Benefit Trust
Share Issue/Capital Change
2020-10-13 English
Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™
Capital/Financing Update
2020-10-09 English
Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US
Regulatory Filings
2020-10-06 English
BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV
Regulatory Filings
2020-08-24 English
Holding(s) in Company
Major Shareholding Notification
2020-08-19 English
Holding(s) in Company
Major Shareholding Notification
2020-08-19 English
Holding(s) in Company
Major Shareholding Notification
2020-08-19 English
Admission to Trading on Euronext Brussels
Share Issue/Capital Change
2020-08-18 English
Acacia Pharma Group plc - Single prospectus
Regulatory Filings
2020-08-17 English
Publication of Prospectus
Report Publication Announcement
2020-08-14 English
Results of Placing
Capital/Financing Update
2020-08-14 English
Proposed Capital Raising by way of a Placing of New Ordinary Shares
Capital/Financing Update
2020-08-13 English
Interim Results for the Six Months ended 30 June 2020
Interim / Quarterly Report H1 2020
2020-08-13 English
Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®
Regulatory Filings
2020-07-27 English
Holding(s) in Company
Major Shareholding Notification
2020-07-21 English
Holding(s) in Company
Major Shareholding Notification
2020-07-21 English
Holding(s) in Company
Major Shareholding Notification
2020-07-21 English
Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies
Share Issue/Capital Change
2020-07-16 English
Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV
Regulatory Filings
2020-07-15 English
Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedatio
Regulatory Filings
2020-07-02 English
TR-1 - Standard form for notification of major holdings
Major Shareholding Notification
2020-06-23 English
TR-1 - Standard form for notification of major holdings
Major Shareholding Notification
2020-06-23 English
TR-1 - Standard form for notification of major holdings
Major Shareholding Notification
2020-06-23 English
TR-1 - Standard form for notification of major holdings
Major Shareholding Notification
2020-06-23 English
Issue of equity
Share Issue/Capital Change
2020-06-23 English
Issue of equity on exercise of options
Share Issue/Capital Change
2020-06-04 English
Issue of equity on exercise of options
Share Issue/Capital Change
2020-06-04 English
ACPH AGM results 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-08 English
Notice of AGM 2020 - change of venue
Regulatory Filings
2020-04-08 English
Proxy form
Proxy Solicitation & Information Statement
2020-04-08 English
Notice of AGM 2020
Proxy Solicitation & Information Statement
2020-04-08 English
Acacia Pharma Group plc - Single prospectus
Regulatory Filings
2020-04-07 English